DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 45 · July 2012 DOI: 10.1055/s-002-23423

Review

167
Riemann, D.; Spiegelhalder, K.; Nissen, C.; Hirscher, V.; Baglioni, C.; Feige, B.: REM Sleep Instability – A New Pathway for Insomnia?

Original Paper

177
Li, Y.-M.; Zhao, J.-P.; Ou, J.-J.; Wu, R.-R.: Efficacy and Tolerability of Ziprasidone vs. Olanzapine in Naive First-Episode Schizophrenia: A 6-Week, Randomized, Open-Label, Flexible-Dose Study
182
Huber, M.; Kölzsch, M.; Rapp, M. A.; Wulff, I.; Kalinowski, S.; Bolbrinker, J.; Hofmann, W.; Scholze, J.; Dräger, D.; Kreutz, R.: Antipsychotic Drugs Predominate in Pharmacotherapy of Nursing Home Residents with Dementia
189
Stein, M.; Dietrich, D. E.; Agelink, M. W.; Becker, W.; Chrysanthou, C.; Driessen, M.; Kruse, G.; Machleidt, W.; Reker, T.; Schneider, U.; Schulze Mönking, H.; Emrich, H. M.; Arolt, V.; Rothermundt, M.: Naturalistic Pharmacotherapy of Acute Episodes of Schizophrenic Disorders in Comparison to Treatment Guidelines
196
Schoemaker, J.; Stet, L.; Vrijland, P.; Naber, D.; Panagides, J.; Emsley, R.: Long-Term Efficacy and Safety of Asenapine or Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder: An Extension Study

Letter

204
Loayza, N.; Crettol, S.; Riquier, F.; Eap, C. B.: Adherence to Antidepressant Treatment: What the Doctor Thinks and What the Patient Says